$44.66
+1.02%
N/A+$0.45
Healthcare
Drug Manufacturers - General
NASDAQ
Active Trading
Sanofi operates as a leading global pharmaceutical enterprise, dedicated to the research, development, production, and distribution of a wide array of therapeutic ...
Financial highlights
Latest / TTM · 6 periods
Snapshot
Latest / TTM: 2026-07-22
Gross Margin
—
Net Margin
—
P/E Ratio
—
Debt / Equity
—
Profitability
Profitability table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Gross MarginGross profit as a percentage of revenue. | 68.7% | 70.7% | 69.7% | 70.2% | 72.1% | — |
| Operating MarginOperating income as a percentage of revenue. | 20.7% | 25.1% | 16.7% | 16.4% | 20.5% | — |
| Net MarginNet income as a percentage of revenue. | 15.9% | 20.6% | 13.0% | 12.6% | 16.7% | — |
| EBITDA MarginEBITDA divided by revenue. | 29.5% | 33.3% | 27.4% | 24.9% | 26.7% | — |
| Pre-tax MarginPre-tax profit as a percentage of revenue. | 20.0% | 24.6% | 14.7% | 15.3% | 12.9% | — |
Liquidity & leverage
Liquidity & leverage table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Current RatioCurrent assets divided by current liabilities. | 1.44 | 1.42 | 1.27 | 1.46 | 1.09 | — |
| Quick RatioLiquid assets divided by current liabilities. | 1.03 | 1.05 | 0.87 | 1.14 | 0.73 | — |
| Cash RatioCash and equivalents divided by current liabilities. | 0.47 | 0.53 | 0.36 | 0.26 | 0.27 | — |
| Debt / AssetsDebt as a share of total assets. | 18.6% | 16.7% | 14.8% | 13.5% | 16.0% | — |
| Debt / EquityDebt compared with shareholder equity. | 0.33 | 0.28 | 0.25 | 0.23 | 0.28 | — |
Operating efficiency
Operating efficiency table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Receivables TurnoverHow often receivables are collected in a year. | 4.00x | 3.77x | 3.77x | 4.17x | 4.23x | — |
| Inventory TurnoverHow often inventory is sold in a year. | 1.41x | 1.33x | 1.31x | 1.40x | 1.28x | — |
| Payables TurnoverHow often payables are paid in a year. | 1.98x | 1.74x | 1.72x | 1.75x | 1.77x | — |
| Asset TurnoverRevenue generated per dollar of assets. | 0.33x | 0.32x | 0.33x | 0.33x | 0.37x | — |
| Working Capital TurnoverRevenue generated per dollar of working capital. | 3.30x | 4.20x | 5.04x | 4.45x | 5.83x | — |
Valuation ratios
Valuation ratios table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| P/E RatioPrice paid for each dollar of earnings. | 17.73x | 14.20x | 20.99x | 21.22x | 12.89x | — |
| P/B RatioPrice paid for each dollar of book value. | 1.61x | 1.51x | 1.53x | 1.50x | 1.41x | — |
| P/S RatioPrice paid for each dollar of sales. | 2.82x | 2.79x | 2.72x | 2.63x | 2.15x | — |
| P/FCF RatioPrice paid for each dollar of free cash flow. | 13.02x | 13.60x | 13.11x | 19.80x | 9.92x | — |
| Dividend YieldAnnual dividend divided by current share price. | 3.6% | 3.7% | 3.9% | 4.0% | 5.3% | — |